We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HWC:NASDAQHancock Whitney Corporation Analysis

Data as of 2026-06-17 - not real-time

$70.86

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Hancock Whitney is currently trading above its short‑term moving averages and the MACD histogram remains positive, confirming a bullish technical backdrop supported by rising volume. The stock’s price sits above the fair‑value estimate derived from discounted cash‑flow analysis, suggesting a degree of overvaluation despite a price‑to‑earnings multiple that undercuts the industry average and a dividend yield that outperforms many peers. Recent all‑cash acquisition activity has been highlighted by analysts as a catalyst, and the upcoming ex‑dividend date adds short‑term income appeal.
Overall, the combination of solid earnings, a stable dividend, and a favorable analyst consensus points to a steady‑hand investment, though the premium pricing and elevated volatility warrant a cautious stance.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Bullish technical indicators (price above SMAs, MACD bullish)
  • Upcoming dividend payout providing near‑term yield
  • Proximity to short‑term resistance level

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Analyst upgrade to "Buy" after acquisition
  • Stable dividend and attractive payout ratio
  • Price premium relative to DCF fair value

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Consistent earnings and solid return metrics
  • Value‑oriented valuation with modest upside
  • Low geographic and currency exposure

Key Metrics & Analysis

Financial Health

Revenue Growth-21.10%
Profit Margin29.89%
P/E Ratio14.6
ROE9.52%
ROA1.18%
P/B Ratio1.3
Op. Cash Flow$552.0M
Industry P/E17.2

Technical Analysis

TrendBullish
RSI59.0
Support$64.87
Resistance$73.15
MA 20$69.09
MA 50$67.96
MA 200$64.76
MACDBullish
VolumeIncreasing
Fear & Greed Index91.25

Valuation

Fair Value$51.31
Target Price$78.22
Upside/Downside10.39%
GradeOvervalued
TypeValue
Dividend Yield2.68%

Risk Assessment

Beta0.93
Volatility24.64%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.